El tratamiento de la hiperprolactinemia: una revisión sistemática y meta-análisis

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2012
Cargando información sobre las referencias

CRD SUMMARY:

The evidence supported the use of dopamine agonists to treat hyperprolactinaemia and reduce associated morbidity; cabergoline was more effective than bromocriptine. Radiotherapy and surgery were efficacious in patients resistant to dopamine agonists. This well-conducted review acknowledged the low quality of the evidence, imprecision and heterogeneity of the results. These limitations should be taken into account when interpreting the conclusions.
Epistemonikos ID: 3e7589a2c9f3bb8175f768af208db4f7d8f540ac
First added on: Jan 13, 2015